Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
Andersson
Borje S
BS
Kashyap
Ashwin
A
Couriel
Daniel
D
Madden
Thomas
T
de Lima
Marcos
M
Thall
Peter F
PF
Fernandez
Hugo
H
Vaughan
William P
WP
Jones
Roy
R
Wingard
John R
JR
Blume
Karl G
KG
Champlin
Richard E
RE
D000284:Administration, Oral; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001682:Biological Availability; D002066:Busulfan / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D015203:Reproducibility of Results
D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan